Get the Stockscreener App
21.36
0.14%
-0.03
After Hours:
21.36
Avadel Pharmaceuticals Plc stock is traded at $21.36, with a volume of 1.26M.
It is down -0.14% in the last 24 hours and up +11.54% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$21.39
Open:
$21.38
24h Volume:
1.26M
Relative Volume:
0.44
Market Cap:
$2.10B
Revenue:
$221.08M
Net Income/Loss:
$-2.92M
P/E Ratio:
-647.27
EPS:
-0.033
Net Cash Flow:
$5.89M
1W Performance:
+0.09%
1M Performance:
+11.54%
6M Performance:
+128.69%
1Y Performance:
+101.32%
1-Day Range:
$21.34
$21.43
1-Week Range:
$21.29
$21.55
52-Week Range:
$6.38
$23.57
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
10 EARLSFORT TERRACE, DUBLIN 2
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
21.36 | 2.10B | 221.08M | -2.92M | 5.89M | -0.033 |
|
ZTS
Zoetis Inc
|
118.66 | 51.85B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.33 | 45.46B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.52 | 42.70B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.79 | 34.62B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
493.99 | 21.03B | 3.08B | 1.24B | 1.07B | 25.61 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-23-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Sep-03-25 | Initiated | Wells Fargo | Equal Weight |
| Jul-18-25 | Resumed | H.C. Wainwright | Buy |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Avadel Pharmaceuticals Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avadel Pharmaceuticals plcAVDL - PR Newswire
Goldman Sachs (EPT)38.5bAVADEL PHARMACEUTICALS PLC - Research Tree
Geode Capital discloses 2.24% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Form 8.3Avadel Pharmaceuticals plc - The Manila Times
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.88% stake in Avadel Pharmaceuticals By Investing.com - Investing.com UK
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Morgan Stanley discloses trading activity in Avadel Pharmaceuticals shares By Investing.com - Investing.com Canada
J.P. Morgan Securities discloses position in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.24% stake in Avadel Pharmaceuticals - Investing.com
Geode Capital discloses 2.25% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Australia
Bank of America discloses 2% stake in Avadel Pharmaceuticals - Investing.com
Citadel Group discloses 1.22% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Morgan Stanley reports trading activity in Avadel Pharmaceuticals shares - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading position in Avadel Pharmaceuticals By Investing.com - Investing.com Nigeria
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals - Investing.com
Janus Henderson discloses 3.73% stake in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities By Investing.com - Investing.com Australia
Morgan Stanley discloses dealings in Avadel Pharmaceuticals securities - Investing.com
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses dealings in Avadel Pharmaceuticals shares - Investing.com
Alkermes, Avadel Pharmaceuticals merger gets HSR clearance in US - MLex
Avadel Pharmaceuticals Acquisition by Alkermes Advances - TradingView
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Trium Capital discloses 1.29% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Citadel Group discloses 1.2% stake in Avadel Pharmaceuticals - Investing.com
Goldman Sachs discloses trading activity in Avadel Pharmaceuticals By Investing.com - Investing.com South Africa
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals - Investing.com
Bank of America discloses 1.12% stake in Avadel Pharmaceuticals By Investing.com - Investing.com India
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com South Africa
Morgan Stanley discloses trading in Avadel Pharmaceuticals shares - Investing.com
Morgan Stanley reports trading in Avadel Pharmaceuticals shares By Investing.com - Investing.com UK
FIL Limited discloses 2.9% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals By Investing.com - Investing.com Canada
REGFIL Limited Avadel Pharma plcForm 8.3AVADEL PHARMACEUTICALS PLC - TradingView
Janus Henderson discloses 3.84% stake in Avadel Pharmaceuticals - Investing.com
Discipline and Rules-Based Execution in AVDL Response - news.stocktradersdaily.com
Avadel Pharmaceuticals PLC (AVDL) - MSN
Is Avadel Pharmaceuticals Still Attractive After a 113.4% One Year Surge in 2025? - Sahm
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story - Yahoo Finance
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Has Avadel’s 115% Rally in 2024 Already Priced In Its Narcolepsy Breakthrough? - Yahoo Finance
Avadel Pharmaceuticals plc and Alkermes plc Announce Proposed Transaction for Acquisition - Quiver Quantitative
Announcement relating to despatch of Rule 15 proposal - The Manila Times
Avadel (NASDAQ: AVDL) sends Rule 15 proposal to equity holders in Alkermes deal - Stock Titan
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.48%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):